LQDA
LQDA
NASDAQ · Pharmaceuticals

Liquidia Corp

$42.30
+0.02 (+0.05%)
As of May 10, 9:56 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 1 7%
Sell 1 7%
Price Target
Analyst Price Target +2.1% upside
Low Target $30.71
Average Target $43.17
High Target $51.56
Current Price $42.30
Current
$42.30
Target
$43.17
$30.71 $43.17 avg $51.56
Scenario Analysis
Bear Case
$30.71
-27.4%
Low target
Base Case
$43.17
+2.1%
Avg target
Bull Case
$51.56
+21.9%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$46.67
-9.4% from high
52-Week Low
$11.85
+257.0% from low
50-Day SMA
$37.31
+13.4% vs SMA
200-Day SMA
$25.48
+66.0% vs SMA
RSI (14)
31.7
Neutral
Target vs 52W High
$43.17
-7.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%